Crystal structure of Staphylococcus aureus tyrosyl-tRNA synthetase in complex with a class of potent and specific inhibitors

被引:167
作者
Qiu, XY
Janson, CA
Smith, WW
Green, SM
McDevitt, P
Johanson, K
Carter, P
Hibbs, M
Lewis, C
Chalker, A
Fosberry, A
Lalonde, J
Berge, J
Brown, P
Houge-Frydrych, CSV
Jarvest, RL
机构
[1] GlaxoSmithKline, King Of Prussia, PA 19406 USA
[2] GlaxoSmithKline, Harlow CM19 5AW, Essex, England
关键词
tyrosyl-tRNA synthase; structure-based drug design; truncation; Staphylococcus aureus;
D O I
10.1110/ps.18001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SB-219383 and its analogues are a class of potent and specific inhibitors of bacterial tyrosyl-tRNA synthetases. Crystal structures of these inhibitors have been solved in complex with the tyrosyl-tRNA synthetase from Staphylococcus aureus, the bacterium that is largely responsible for hospital-acquired infections. The full-length enzyme yielded crystals that diffracted to 2.8 Angstrom resolution, but a truncated version of the enzyme allowed the resolution to be extended to 2.2 Angstrom. These inhibitors not only occupy the known substrate binding sites in unique ways, but also reveal a butyl binding pocket. It was reported that the Bacillus stearothermophilus TyrRS T51P mutant has much increased catalytic activity. The S. aureus enzyme happens to have a proline at position 51. Therefore, our structures may contribute to the understanding of the catalytic mechanism and provide the structural basis for designing novel antimicrobial agents.
引用
收藏
页码:2008 / 2016
页数:9
相关论文
共 21 条
[11]   RECONSTRUCTION BY SITE-DIRECTED MUTAGENESIS OF THE TRANSITION-STATE FOR THE ACTIVATION OF TYROSINE BY THE TYROSYL-TRANSFER RNA-SYNTHETASE - A MOBILE LOOP ENVELOPES THE TRANSITION-STATE IN AN INDUCED-FIT MECHANISM [J].
FERSHT, AR ;
KNILLJONES, JW ;
BEDOUELLE, H ;
WINTER, G .
BIOCHEMISTRY, 1988, 27 (05) :1581-1587
[12]  
FERSHT AR, 1985, ENZYME STRUCTURE FUN
[13]   SB-219383, a novel tyrosyl tRNA synthetase inhibitor from a Micromonospora sp II.: Structure determination [J].
Houge-Frydrych, CSV ;
Readshaw, SA ;
Bell, DJ .
JOURNAL OF ANTIBIOTICS, 2000, 53 (04) :351-356
[14]   THE EFFICACY OF INTRANASAL MUPIROCIN IN THE PREVENTION OF STAPHYLOCOCCAL INFECTIONS - A REVIEW OF RECENT EXPERIENCE [J].
HUDSON, IRB .
JOURNAL OF HOSPITAL INFECTION, 1994, 27 (02) :81-98
[15]   Potent synthetic inhibitors of tyrosyl tRNA synthetase derived from C-pyranosyl analogues of SB-219383 [J].
Jarvest, RL ;
Berge, JM ;
Brown, P ;
Hamprecht, DW ;
McNair, DJ ;
Mensah, L ;
O'Hanlon, PJ ;
Pope, AJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (05) :715-718
[16]   Human tyrosyl tRNA synthetase shares amino acid sequence homology with a putative cytokine [J].
Kleeman, TA ;
Wei, DB ;
Simpson, KL ;
First, EA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (22) :14420-14425
[17]   TRANSITION-STATE STABILIZATION IN THE MECHANISM OF TYROSYL-TRANSFER RNA-SYNTHETASE REVEALED BY PROTEIN ENGINEERING [J].
LEATHERBARROW, RJ ;
FERSHT, AR ;
WINTER, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (23) :7840-7844
[18]  
McRee DE., 1999, PRACTICAL PROTEIN CR, P91, DOI 10.1016/B978-012486052-0/50005-1
[19]   CRYSTALLIZATION AND PRELIMINARY X-RAY-DIFFRACTION STUDIES ON TYROSYL-TRANSFER RNA-SYNTHETASE FROM BACILLUS-STEAROTHERMOPHILUS [J].
REID, BR ;
KOCH, GLE ;
BOULANGER, Y ;
HARTLEY, BS ;
BLOW, DM .
JOURNAL OF MOLECULAR BIOLOGY, 1973, 80 (01) :199-+
[20]   Aminoacyl tRNA synthetases as targets for new anti-infectives [J].
Schimmel, P ;
Tao, JS ;
Hill, J .
FASEB JOURNAL, 1998, 12 (15) :1599-1609